Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Pak J Med Sci ; 38(8): 2253-2258, 2022.
Article in English | MEDLINE | ID: mdl-36415262

ABSTRACT

Objectives: To investigate the risk factors of lower limb amputation, and help physicians better understand the clinical characteristics of patients with diabetic foot, and make treatment strategies for these patients correctly. Methods: In this study, the inpatients with diabetic foot treated in our hospital form January 2013 to February 2021 were reviewed retrospectively. The patients were divided into amputation and conservative treatment groups. The variables of the patients, consisting of age, gender, smoking history, alcohol use, diabetes and ulcer duration, ulcer size, Wagner classification, ankle brachial index, previous amputation history, laboratory data, and medical comorbidities including hypertension, coronary artery disease, peripheral arterial disease, chronic renal insufficiency, retinopathy, and sequelae of cerebral infarction were selected for analysis to determine the risk factors of lower limb amputation. Results: In this study, a total of 856 patients with diabetic foot were enrolled, in which 487 patients received amputation surgeries, and the amputation rate was 56.9%. There were significant differences between the two groups in gender (p=0.014), smoking history (p=0.011), ulcer duration (p=0.023), ulcer size (p=0.000), Wagner classification (p=0.000), ABI (p=0.031), peripheral arterial disease (p=0.000), HDL-C (p=0.013), osteomyelitis (p=0.000), and fibrinogen (p=0.001). A stepwise multiple logistic regression analysis revealed that male gender (p=0.003), larger ulcer size (p=0.001), higher Wagner classification grades (p=0.002), higher rate of peripheral arterial disease (p=0.02) and osteomyelitis (p=0.0001), and increased fibrinogen level (p=0.004) were independent risk factors of lower limb amputation in patients with diabetic foot. Conclusion: The diabetic foot patients with male sex, larger ulcer size, higher grade of Wagner classification, peripheral arterial disease or higher fibrinogen level may face higher risk of lower limb amputation.

2.
Genome Announc ; 5(6)2017 Feb 09.
Article in English | MEDLINE | ID: mdl-28183752

ABSTRACT

Salmonella enterica serovar Typhimurium strains 22495 and 22792, obtained from wild birds, were found to display different virulence attributes in an experimental chicken model. Closed genome sequences were assembled after sequencing with the Roche 454 and Illumina MiSeq platforms. An additional plasmid was present in the more virulent strain 22495.

3.
Glycobiology ; 22(10): 1311-20, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22730466

ABSTRACT

IspC is a novel peptidoglycan (PG) hydrolase that is conserved in Listeria monocytogenes serotype 4b strains and is involved in virulence. The aim of this study was to establish the hydrolytic bond specificity of IspC. Purified L. monocytogenes peptidoglycan was digested by recombinant IspC and the resulting muropeptides were separated by reverse phase high-performance liquid chromatography. The structure of each muropeptide was determined using matrix-assisted laser desorption ionization (MALDI)-time-of-flight mass spectrometry in combination with MALDI-post-source decay mass spectrometry. The structure of muropeptides resulting from IspC-mediated hydrolysis indicated that IspC has N-acetylglucosaminidase activity. These muropeptides also had a high proportion of N-acetylated glucosamine residues. To determine whether IspC is more effective at hydrolysing N-acetylated peptidoglycan than de-N-acetylated peptidoglycan, a peptidoglycan deacetylase (PgdA) in-frame deletion mutant was created. This mutant was shown to have fully N-acetylated peptidoglycan and was more susceptible to hydrolysis by IspC when compared with the partially de-N-acetylated wild-type peptidoglycan. This indicates that IspC is more efficient when hydrolysing a fully N-acetylated peptidoglycan substrate. The finding that IspC acts as an N-acetylglucosaminidase is consistent with its categorization, based on amino acid sequence, as a member of the GH73 family. As with other members of this family, de-N-acetylation seems to be an important mechanism for regulating the activity of IspC.


Subject(s)
Acetylglucosaminidase/metabolism , Listeria monocytogenes/enzymology , Acetylglucosaminidase/chemistry , Acetylglucosaminidase/isolation & purification , Chromatography, High Pressure Liquid , Enzyme Activation , Hydrolysis , Mass Spectrometry , Peptidoglycan/chemistry , Peptidoglycan/metabolism
4.
Proc Natl Acad Sci U S A ; 107(11): 5154-9, 2010 Mar 16.
Article in English | MEDLINE | ID: mdl-20133735

ABSTRACT

Bacterial nucleoid-associated proteins play important roles in chromosome organization and global gene regulation. We find that Lsr2 of Mycobacterium tuberculosis is a unique nucleoid-associated protein that binds AT-rich regions of the genome, including genomic islands acquired by horizontal gene transfer and regions encoding major virulence factors, such as the ESX secretion systems, the lipid virulence factors PDIM and PGL, and the PE/PPE families of antigenic proteins. Comparison of genome-wide binding data with expression data indicates that Lsr2 binding results in transcriptional repression. Domain-swapping experiments demonstrate that Lsr2 has an N-terminal dimerization domain and a C-terminal DNA-binding domain. Nuclear magnetic resonance analysis of the DNA-binding domain of Lsr2 and its interaction with DNA reveals a unique structure and a unique mechanism that enables Lsr2 to discriminately target AT-rich sequences through interactions with the minor groove of DNA. Taken together, we provide evidence that mycobacteria have employed a structurally distinct molecule with an apparently different DNA recognition mechanism to achieve a function similar to the Enterobacteriaceae H-NS, likely coordinating global gene regulation and virulence in this group of medically important bacteria.


Subject(s)
AT Rich Sequence/genetics , DNA, Bacterial/metabolism , DNA-Binding Proteins/metabolism , Genes, Bacterial/genetics , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/pathogenicity , DNA-Binding Proteins/chemistry , Models, Molecular , Mycobacterium tuberculosis/immunology , Protein Binding , Protein Multimerization , Protein Structure, Secondary , Protein Structure, Tertiary , Solutions , Virulence/genetics
5.
J Bacteriol ; 190(21): 7052-9, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18776007

ABSTRACT

Lsr2 is a small, basic protein present in Mycobacterium and related actinomycetes. Our previous in vitro biochemical studies showed that Lsr2 is a DNA-bridging protein, a property shared by H-NS-like proteins in gram-negative bacteria. Here we present in vivo evidence based on genetic complementation experiments that Lsr2 is a functional analog of H-NS, the first such protein identified in gram-positive bacteria. We show that lsr2 can complement the phenotypes related to hns mutations in Escherichia coli, including beta-glucoside utilization, mucoidy, motility, and hemolytic activity. We also show that Lsr2 binds specifically to H-NS-regulated genes and the repression of hlyE by Lsr2 can be partially eliminated by overexpression of slyA, suggesting that the molecular mechanisms of Lsr2 repression and depression are similar to those of H-NS. The functional equivalence of these two proteins is further supported by the ability of hns to complement the lsr2 phenotype in Mycobacterium smegmatis. Taken together, our results demonstrate unequivocally that Lsr2 is an H-NS-like protein.


Subject(s)
Antigens, Bacterial/metabolism , Bacterial Proteins/metabolism , DNA-Binding Proteins/metabolism , Mycobacterium smegmatis/metabolism , Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Blotting, Western , DNA-Binding Proteins/genetics , Electrophoretic Mobility Shift Assay , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Genetic Complementation Test , Hemolysin Proteins/genetics , Hemolysin Proteins/metabolism , Mycobacterium smegmatis/genetics , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/metabolism , Protein Binding , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/genetics , Transcription Factors/metabolism
6.
Microbiology (Reading) ; 154(Pt 7): 1900-1913, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18599819

ABSTRACT

We have recently concluded that a Listeria monocytogenes 86 kDa immunogenic surface protein, IspC, is a cell wall-anchored peptidoglycan hydrolase (autolysin), capable of degrading the cell wall peptidoglycan of the bacterium itself. To determine if this enzyme has any biological functions and/or plays a role in virulence, we in-frame-deleted the ispC gene from the L. monocytogenes chromosome. This DeltaispC mutant exhibited complete abrogation of expression of IspC and displayed no defects in in vitro growth, colony and microscopic morphologies, or biochemical characteristics. Lack of IspC led to attenuated virulence in mice, evidenced by a significant reduction in bacterial counts in livers and brains and no mortality compared with the wild-type. Furthermore, the data from assays using various eukaryotic cells for adhesion, invasion, actin tail formation, plaque formation and intracellular growth indicated that the mutant was severely attenuated in virulence in a cell culture model in a cell type-dependent manner. The findings that (i) the mutant was impaired for adhesion to certain eukaryotic cells, and (ii) both purified IspC and its C-terminal cell wall-binding domain were capable of binding sheep choroid plexus (SCP) epithelial cells and Vero cells, supported the role of IspC as an adhesin in virulence. The DeltaispC mutant exhibited a marked defect in adhesion to and invasion of SCP cells but not human brain microvascular endothelial cells (HBMEC), suggesting that IspC is necessary for crossing the blood-cerebrospinal fluid barrier. Proteomic and immunological analysis showed a reduced surface expression of some known or putative virulence factors (e.g. ActA, InlC2 and a flagellin homologue, FlaA) due to IspC deficiency. Altogether, this study demonstrates that IspC, expressed as a minor autolysin in vitro, is not important for cell division or separation but is essential for full virulence of L. monocytogenes in vivo.


Subject(s)
Bacterial Proteins/metabolism , Cell Wall/enzymology , Listeria monocytogenes/enzymology , Listeria monocytogenes/pathogenicity , Listeriosis/microbiology , N-Acetylmuramoyl-L-alanine Amidase/metabolism , Proteomics , Animals , Bacterial Adhesion , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Cell Line, Tumor , Cell Wall/genetics , Cell Wall/physiology , Chlorocebus aethiops , Choroid Plexus/microbiology , Endothelial Cells/microbiology , Gene Expression Regulation, Bacterial , Humans , Listeria monocytogenes/genetics , Listeria monocytogenes/physiology , Mice , Mice, Inbred BALB C , N-Acetylmuramoyl-L-alanine Amidase/chemistry , N-Acetylmuramoyl-L-alanine Amidase/genetics , Phenotype , Protein Binding , Protein Structure, Tertiary , Sequence Deletion , Sheep , Species Specificity , Vero Cells , Virulence , Virulence Factors/genetics , Virulence Factors/metabolism
7.
Biochem Biophys Res Commun ; 354(2): 403-8, 2007 Mar 09.
Article in English | MEDLINE | ID: mdl-17239349

ABSTRACT

The 86-kDa protein IspC of 774 amino acids in Listeria monocytogenes serotype 4b has been recently identified as the target of humoral immune response to listerial infection and as a novel surface autolysin. A signal peptide is predicted at the N-terminal end of IspC, but no biochemical data has been shown to confirm the presence of the cleavage site of a signal peptidase. To address this and prepare sufficient amount of the protein for biochemical and structural characterization, we present a strategy for efficient expression and purification of IspC and analyze the purified protein by N-terminal sequencing and mass spectrometry. Expression of IspC in Escherichia coli using a pET30a-based expression construct was efficiently improved by incubating the culture at 37 degrees C for 2h followed by 4 degrees C for 16-18 h. The recombinant product rIspC remained as a soluble form in the cellular extract and was purified to electrophorectic homogeneity by the combination of metal chelate affinity chromatography with cation-exchange chromatography. The IspC was shown to contain a 23-residue N-terminal signal peptide being processed between Thr 23 and Thr 24 in E. coli, resulting in an 84-kDa mature protein. The highly purified form of rIspC from this study, exhibiting both peptidoglycan hydrolase activity and immunogenicity as previously reported, would facilitate further biochemical, structural, and functional studies of this autolysin.


Subject(s)
Bacterial Proteins/metabolism , Escherichia coli/metabolism , Listeria monocytogenes/enzymology , Listeria monocytogenes/immunology , N-Acetylmuramoyl-L-alanine Amidase/metabolism , Protein Sorting Signals/physiology , Aldose-Ketose Isomerases/metabolism , Amino Acid Sequence , Bacteriolysis , Cloning, Molecular , Listeria monocytogenes/classification , Listeria monocytogenes/genetics , Molecular Sequence Data , Multienzyme Complexes/metabolism , Oxidoreductases/metabolism , Protein Precursors/metabolism , Serotyping
8.
J Bacteriol ; 189(5): 2046-54, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17172332

ABSTRACT

We identified and biochemically characterized a novel surface-localized autolysin from Listeria monocytogenes serotype 4b, an 86-kDa protein consisting of 774 amino acids and known from our previous studies as the target (designated IspC) of the humoral immune response to listerial infection. Recombinant IspC, expressed in Escherichia coli, was purified and used to raise specific rabbit polyclonal antibodies for protein characterization. The native IspC was detected in all growth phases at a relatively stable low level during a 22-h in vitro culture, although its gene was transiently transcribed only in the early exponential growth phase. This and our previous findings suggest that IspC is upregulated in vivo during infection. The protein was unevenly distributed in clusters on the cell surface, as shown by immunofluorescence and immunogold electron microscopy. The recombinant IspC was capable of hydrolyzing not only the cell walls of the gram-positive bacterium Micrococcus lysodeikticus and the gram-negative bacterium E. coli but also that of the IspC-producing strain of L. monocytogenes serotype 4b, indicating that it was an autolysin. The IspC autolysin exhibited peptidoglycan hydrolase activity over a broad pH range of between 3 and 9, with a pH optimum of 7.5 to 9. Analysis of various truncated forms of IspC for cell wall-hydrolyzing or -binding activity has defined two separate functional domains: the N-terminal catalytic domain (amino acids [aa] 1 to 197) responsible for the hydrolytic activity and the C-terminal domain (aa 198 to 774) made up of seven GW modules responsible for anchoring the protein to the cell wall. In contrast to the full-length IspC, the N-terminal catalytic domain showed hydrolytic activity at acidic pHs, with a pH optimum of between 4 and 6 and negligible activity at alkaline pHs. This suggests that the cell wall binding domain may be of importance in modulating the activity of the N-terminal hydrolase domain. Elucidation of the biochemical properties of IspC may have provided new insights into its biological function(s) and its role in pathogenesis.


Subject(s)
Listeria monocytogenes/enzymology , Listeriosis/immunology , N-Acetylmuramoyl-L-alanine Amidase/physiology , Animals , Antibody Formation , Catalytic Domain , Female , Hydrogen-Ion Concentration , Listeria monocytogenes/immunology , Listeria monocytogenes/pathogenicity , N-Acetylmuramoyl-L-alanine Amidase/analysis , N-Acetylmuramoyl-L-alanine Amidase/chemistry , Rabbits , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...